The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.

@article{Lynch2008ThePO,
  title={The promise of 4-1BB (CD137)-mediated immunomodulation and the immunotherapy of cancer.},
  author={David H. Lynch},
  journal={Immunological reviews},
  year={2008},
  volume={222},
  pages={277-86}
}
The continuing efforts in biomedical research to develop new therapies for cancer are entering an exciting new phase. Research over the past two to three decades has yielded a much more detailed understanding of the complexities of the cellular and molecular interactions involved in the generation and regulation of immune responses. We are also gaining… CONTINUE READING